Interventions for improving blood flow, oxygen availability and the balance between oxygen supply and demand in the acutely ischaemic myocardium.
D000208:Acute Disease; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000818:Animals; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D003326:Coronary Circulation; D004285:Dogs; D006931:Hyperbaric Oxygenation; D009203:Myocardial Infarction / Q000628:therapy*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D014665:Vasodilator Agents; D010100:Oxygen